Furthermore, Robin Energy’s Board of Directors has approved a $1 million share repurchase program, allowing the company to buy back its common shares through open market or privately negotiated ...

The FBI is warning about a new type of crime that targets ATMs around the country. In a Feb. 19 alert,incidents the FBI said it has seen a sharp uptick in “ATM jackpotting,” a method that uses malware ...

A desktop-based ATM simulation application built with Java and Swing GUI framework. This application provides a complete banking system where users can perform various transactions through an ATM-like ...

The FBI says malware-wielding criminals walked away with $20 million from ATMs across the United States last year thanks to "cash-out" attacks. (Image: Shutterstock) Malware-wielding criminals ...

ATM “jackpotting” schemes are on the rise across the country, according to the Federal Bureau of Investigation. Hackers are exploiting a mix of “physical and software vulnerabilities in ATMs” to get ...

GOUVERNEUR, N.Y., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX:TI, NYSE-A:TII), (“Titan” or the “Company”) today announced that it has filed a base shelf prospectus in Canada dated ...

NCR Atleos Corporation, a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced an advancement in the dual-sided ATM concept, ...

ATLANTA--(BUSINESS WIRE)-- NCR Atleos (NATL) Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today ...

ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced an ...

NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced an advancement in the ...

Inhibikase Therapeutics ( (IKT)) has shared an announcement. On December 19, 2025, Inhibikase Therapeutics, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to ...